| RS192822778 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS192823093 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1928233784 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1928241490 |
RS1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Juvenile retinoschisis |
| RS192826739 |
GPAT2
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS192827581 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD26-related disorder, ANKRD26-related disorder |
| RS1928277140 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928279286 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928285510 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1928287177 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1928287649 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS192831239 |
PAICS
|
Health Risk |
Pathogenic |
Phosphoribosylaminoimidazole carboxylase deficiency, Phosphoribosylaminoimidazole carboxylase deficiency |
| RS1928319806 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928321045 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928323615 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS1928326107 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928326524 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928326653 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1928326804 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1928349391 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928350631 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928355133 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928355433 |
CYB5R3
|
Health Risk |
Likely pathogenic |
— |
| RS1928356260 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928358562 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192835895 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1928359639 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192836330 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS1928365677 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928365871 |
FRMD7
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1928365978 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928369132 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928370474 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928374520 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928375176 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928375454 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1928379522 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1928380918 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1928383077 |
PCDH19
|
Health Risk |
Likely pathogenic |
Refractory epilepsy with Lennox Gastaut syndrome, Refractory epilepsy with Lennox Gastaut syndrome |
| RS1928383528 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192838388 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS1928388987 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928395285 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928395725 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1928398128 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928400256 |
SMARCB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1928400754 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1928405180 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928405402 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928405533 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS1928406047 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928406808 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1928406948 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1928407149 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928407580 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1928407939 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928409516 |
PCDH19
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS1928410872 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928411447 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS1928424117 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928424443 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928426655 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192842970 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 1, Stickler syndrome type 2 |
| RS1928431321 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928435502 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS192843629 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1928436463 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS1928437614 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928438552 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928439241 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928439511 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928440191 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928441222 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928445406 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928446616 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928448324 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928449770 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928452385 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192845338 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1928454112 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928457396 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928457666 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928459143 |
PCDH19
|
Health Risk |
Pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy |
| RS1928460473 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928462092 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928462873 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928463633 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928471120 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1928472916 |
FRMD7
|
Health Risk |
Pathogenic |
— |
| RS1928479952 |
PCDH19
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Developmental and epileptic encephalopathy |
| RS1928480582 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS192849943 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LRP2-related disorder |
| RS1928500368 |
RS1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS192853475 |
GYS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS1928536961 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1928539937 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS1928556991 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1928558096 |
SNAP29
|
Health Risk |
Likely pathogenic |
— |
| RS1928559435 |
SNAP29
|
Health Risk |
Pathogenic/Likely pathogenic |
CEDNIK syndrome, CEDNIK syndrome |
| RS192857413 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |